Connective tissue disease-associated ILD

B. Crestani (Paris, France)

Source: International Congress 2018 – State of the art session: Interstitial lung diseases
Session: State of the art session: Interstitial lung diseases
Session type: Symposium
Number: 4900
Disease area: Interstitial lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Crestani (Paris, France). Connective tissue disease-associated ILD. International Congress 2018 – State of the art session: Interstitial lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Connective tissue disease-associated lung disease
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Connective tissue disease-associated lung disease
Source: ERS Course 2016
Year: 2016




Connective tissue disease-associated lung disease
Source: ERS Course 2019- Interstitial Lung Diseases
Year: 2018

Connective tissue disease-associated lung disease
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Connective tissues disease-associated lung disease
Source: School Course 2014 - Interstitial lung diseases
Year: 2014

Connective tissue disease-associated lung disorders
Source: Eur Respir Mon; 2009: 46: 225–250
Year: 2009

Connective tissue disease-related interstitial lung disease and lung cancer
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018


Connective tissue diseases, multimorbidity and the ageing lung
Source: Eur Respir J 2016; 47:1535-1558
Year: 2016



Systemic and connective tissue diseases
Source: Eur Respir Monogr 2018; 81: 254-266
Year: 2018


Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Lung transplantation for systemic sclerosis and other connective tissue diseases
Source: International Congress 2017 – Difficult indications for lung transplantation
Year: 2017


Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Interstitial lung disease in the connective tisssue disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients
Source: Eur Respir J 2014; 44: 963-972
Year: 2014



Anti periplakin antibodies in connective tissue-associated lung fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Disease patterns in connective tissue disease-associated interstitial lung disease: a population based study
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019



Occult connective tissue diseases mimicking idiopathic interstitial pneumonias
Source: Eur Respir J 2008; 31: 11-20
Year: 2008



Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD?
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013